There have been a lot of high-profile acquisitions in the biopharmaceutical space, and it probably isn’t going to stop at AbbVie’s $63 billion offer for Allergan. These two biotech stocks are …

More 2 Stocks That Could Be the Next Biotech Buyouts Videos